The first high-performance plasma biomarkers for Alzheimer's disease (AD) have been validated in an international collaborative study, which was reported in the Jan. 31, 2018, edition of Nature.
The first high-performance plasma biomarkers for Alzheimer's disease (AD) have been validated in an international collaborative study, which was reported in the Jan. 31, 2018, edition of Nature.
HONG KONG – The elucidation of the detailed three-dimensional (3-D) atomic structure of a key drug receptor will facilitate the design of new polypharmacology drugs capable of acting on multiple targets, opening up new ways to develop drugs for the treatment of complex diseases.
The elucidation of the detailed three-dimensional (3-D) atomic structure of a key drug receptor will facilitate the design of new polypharmacology drugs capable of acting on multiple targets, opening up new ways to develop drugs for the treatment of complex diseases.
In a new study, researchers at the U.K.'s University of Liverpool and Johns Hopkins University School of Medicine in Baltimore have jointly developed a new long-acting nanomedicine-based delivery system for preventing malaria.
A new genomics system developed to identify interferon-sensitive mutations was used to generate an attenuated hyper-interferon (IFN)-susceptible influenza virus vaccine candidate, which not only elicited robust immune responses but could also be used to produce vaccines against other pathogens, Chinese and U.S. researchers reported in the Jan. 19, 2018, edition of Science.
In a new study, researchers at the U.K.'s University of Liverpool and Johns Hopkins University School of Medicine in Baltimore have jointly developed a new long-acting nanomedicine-based delivery system for preventing malaria.
